- Woman 18 years old and older- Patient with HER2-positive breast cancer, histologically confirmed, eligible to a neoadjuvant chemotherapy and an anti-HER2 target therapy- Covered by social security system- Signed informed consent- Certificate of non-contraindication to the practice of physical activity. The gene discussed is ERBB2; the disease is breast carcinoma.